Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

SMTL ID : 4bks.4 (3 other biounits)

von Hippel Lindau protein:ElonginB:ElonginC complex, in complex with (2S,4R)-1-ethanoyl-N-[[4-(1,3-oxazol-5-yl)phenyl]methyl]-4-oxidanyl-pyrrolidine-2-carboxamide

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.20 Å
Oligo State
hetero-oligomer
Ligands
1 x X6C: (2S,4R)-1-ETHANOYL-N-[[4-(1,3-OXAZOL-5-YL)PHENYL]METHYL]-4-OXIDANYL-PYRROLIDINE-2-CARBOXAMIDE(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Dias, D.M. et al., Is NMR Fragment Screening Fine-Tuned to Assess Druggability of Protein-Protein Interactions?. Acs Med.Chem.Lett. (2014)
Release Date
2013-11-27
Peptides
TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2: A
TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 1: B
VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOR: C
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
D
B
E
C
F

TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 2

TRANSCRIPTION ELONGATION FACTOR B POLYPEPTIDE 1

VON HIPPEL-LINDAU DISEASE TUMOR SUPPRESSOR

Related Entries With Identical Sequence

1lqb.1 | 1lqb.2 | 2c9w.1 | 2izv.1 | 3dcg.1 | 3dcg.2 | 3zng.1 | 3zng.2 | 3zrc.1 | 3zrc.2 | 3zrc.3 | 3zrc.4 | 3zrf.1 | 3zrf.2 | 3zrf.3 | 3zrf.4 | 3ztc.1 | 3ztc.2 | 3ztc.3 | 3ztc.4 | 3ztd.1 | 3ztd.2 | 3ztd.3 | 3ztd.4 | 3zun.1 | 3zun.2 | 3zun.3 | 3zun.4 | 4ajy.1 | 4awj.1  more...